Skip to content

NAGE NAGE Restricted Cash

Restricted Cash at other companies

USANA Health Sciences logo
USANA Health SciencesUSNA
$2.91M+5.5%
BellRing Brands logo
BellRing BrandsBRBR
$600K-96.3%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$36K+5.9%
Darling Ingredients Inc. logo
Darling Ingredients Inc.DAR
$22.22M-44.3%

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCash.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's restricted cash?
NAGE (NAGE) reported restricted cash of $152K in Q1 2026.
How has NAGE's restricted cash changed year-over-year?
NAGE's restricted cash decreased by 0.0% year-over-year, from $152K to $152K.
What is the long-term trend for NAGE's restricted cash?
Over 4 years (2021 to 2025), NAGE's restricted cash has grown at a 0.0% compound annual growth rate (CAGR), from $152K to $152K.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.